Denosumab Related Osteonecrossi of the Jaw : : an Emergent & Potentially

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03638726` - Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification	Phase 4
Completed	`NCT05007041` - Simultaneous RZV and aIIV4 Vaccination	Phase 4
Suspended	`NCT02559960` - Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study
Completed	`NCT05266300` - Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.
Completed	`NCT03112083` - Safety and Tolerability of Krill Powder Supplement in Slightly Overweight People With Moderately Elevated Blood Pressure	N/A
Completed	`NCT05028361` - Simultaneous mRNA COVID-19 and IIV4 Vaccination Study	Phase 4
Completed	`NCT04284553` - Optimizing Electronic Health Record Prompts With Behavioral Economics to Improve Prescribing for Older Adults	N/A
Recruiting	`NCT06120712` - A Phase Ⅰb Study on Autologous GC101 TIL Injection for the Treatment of Advanced Melanoma (MIZAR-002)	Phase 1/Phase 2
Completed	`NCT04181775` - Effectiveness of an ADE-related Hospitalization Risk Prediction Tool for Patients (ADE-RED)
Completed	`NCT02906657` - Medication Reconciliation Using Electronic Pharmaceutical Record: A Multicenter Study in the Hospitalized Elderly	N/A
Completed	`NCT03640273` - Efficacy and Adverse Effects of Prapchompoothaweep Remedy and Loratadine for Treatment in AR Patients	Phase 2
Completed	`NCT02162147` - How Safe Are Our Pediatric Emergency Departments?	N/A
Completed	`NCT01897870` - The Effect of a Pharmacist Home Visit on Drug-related Problems Post-discharge.	N/A
Completed	`NCT03725046` - Impact of an Optimized Communication on the Readmission for Adverse Drug Event	N/A
Recruiting	`NCT04635956` - Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas	Phase 2
Active, not recruiting	`NCT05538065` - NUDGE-EHR Replication Trial at Mass General Brigham	N/A
Completed	`NCT03442010` - Adverse Drug Events at Emergency Department
Recruiting	`NCT04791150` - Rheumatologic Adverse Events and Cancer Immunotherapy	N/A
Completed	`NCT02864030` - PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment	Phase 4
Completed	`NCT03665402` - A Pharamcogenomic Study for Isoniazid According to NAT2 Polymorphism Status	N/A

NCT number	NCT03808285
Study type	Observational
Source	Hospices Civils de Lyon
Contact
Status	Completed
Phase
Start date	January 1, 2013
Completion date	December 31, 2018

Denosumab Related Osteonecrossi of the Jaw : : an Emergent and Potentially Complex Bone and Joint Infection

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms